Literature DB >> 19172218

Patent foramen ovale closure and migraine: are we following the wrong pathway?

Tom Sarens, Luc Herroelen, Kristien Van Deyk, Werner Budts.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2009        PMID： 19172218     DOI： 10.1007/s00415-009-0126-9

Source DB:  PubMed          Journal:  J Neurol        ISSN： 0340-5354            Impact factor:   4.849


× No keyword cloud information.
  8 in total

1.  A quantification of the placebo response in migraine prophylaxis.

Authors:  P-H M van der Kuy; J J H M Lohman
Journal:  Cephalalgia       Date:  2002-05       Impact factor: 6.292

2.  Migraine in the United States: epidemiology and patterns of health care use.

Authors:  R B Lipton; A I Scher; K Kolodner; J Liberman; T J Steiner; W F Stewart
Journal:  Neurology       Date:  2002-03-26       Impact factor: 9.910

3.  Potential source of cerebral embolism in migraine with aura: a transcranial Doppler study.

Authors:  G P Anzola; M Magoni; M Guindani; L Rozzini; G Dalla Volta
Journal:  Neurology       Date:  1999-05-12       Impact factor: 9.910

4.  Effect on migraine of closure of cardiac right-to-left shunts to prevent recurrence of decompression illness or stroke or for haemodynamic reasons.

Authors:  P T Wilmshurst; S Nightingale; K P Walsh; W L Morrison
Journal:  Lancet       Date:  2000-11-11       Impact factor: 79.321

5.  Migraine Intervention With STARFlex Technology trial: a controversial trial of migraine and patent foramen ovale closure.

Authors:  John D Carroll
Journal:  Circulation       Date:  2008-03-10       Impact factor: 29.690

6.  Migraine with aura and right-to-left shunt on transcranial Doppler: a case-control study.

Authors:  M Del Sette; S Angeli; M Leandri; G Ferriero; G L Bruzzone; C Finocchi; C Gandolfo
Journal:  Cerebrovasc Dis       Date:  1998 Nov-Dec       Impact factor: 2.762

7.  Migraine Intervention With STARFlex Technology (MIST) trial: a prospective, multicenter, double-blind, sham-controlled trial to evaluate the effectiveness of patent foramen ovale closure with STARFlex septal repair implant to resolve refractory migraine headache.

Authors:  Andrew Dowson; Michael J Mullen; Richard Peatfield; Keith Muir; Arif Anis Khan; Christopher Wells; Susan L Lipscombe; Trevor Rees; Joseph V De Giovanni; W Lindsay Morrison; David Hildick-Smith; Giles Elrington; W Stewart Hillis; Iqbal S Malik; Anthony Rickards
Journal:  Circulation       Date:  2008-03-03       Impact factor: 29.690

Review 8.  The patent foramen ovale-migraine question.

Authors:  S J Tepper; F D Sheftell; M E Bigal
Journal:  Neurol Sci       Date:  2007-05       Impact factor: 3.307
  8 in total
  3 in total

1.  Strong association between right-to-left shunt and migraine.

Authors:  J G L M Luermans; M W F van Gent; C J J Westermann; H W M Plokker; M C Post; W I H L Budts
Journal:  Neth Heart J       Date:  2010-05       Impact factor: 2.380

2.  Relationship between migraine and right-to-left shunt in children: editorial.

Authors:  Werner Budts
Journal:  Eur J Pediatr       Date:  2010-09-28       Impact factor: 3.183

3.  A Nomogram for the Prediction of Cessation of Migraine Among Patients With Patent Foramen Ovale After Percutaneous Closure.

Authors:  Enfa Zhao; Hang Xie; Yushun Zhang
Journal:  Front Neurol       Date:  2020-10-23       Impact factor: 4.003
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.